Highlights

[VERSATL] QoQ TTM Result on 2016-09-30 [#2]

Stock [VERSATL]: VERSATILE CREATIVE BHD
Announcement Date 24-Nov-2016
Admission Sponsor -
Sponsor -
Financial Year 31-Mar-2017
Quarter 30-Sep-2016  [#2]
Profit Trend QoQ -     -183.66%    YoY -     86.63%
Quarter Report


View:


Show?  QoQ % Horiz. %

TTM Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 48,475 47,481 46,625 45,404 45,583 44,467 44,882 5.27%
  QoQ % 2.09% 1.84% 2.69% -0.39% 2.51% -0.92% -
  Horiz. % 108.01% 105.79% 103.88% 101.16% 101.56% 99.08% 100.00%
PBT 1,585 731 -2,625 -1,789 -586 -1,995 -10,315 -
  QoQ % 116.83% 127.85% -46.73% -205.29% 70.63% 80.66% -
  Horiz. % -15.37% -7.09% 25.45% 17.34% 5.68% 19.34% 100.00%
Tax -660 -660 -69 -69 -69 -69 -126 201.92%
  QoQ % 0.00% -856.52% 0.00% 0.00% 0.00% 45.24% -
  Horiz. % 523.81% 523.81% 54.76% 54.76% 54.76% 54.76% 100.00%
NP 925 71 -2,694 -1,858 -655 -2,064 -10,441 -
  QoQ % 1,202.82% 102.64% -44.99% -183.66% 68.27% 80.23% -
  Horiz. % -8.86% -0.68% 25.80% 17.80% 6.27% 19.77% 100.00%
NP to SH 925 71 -2,694 -1,858 -655 -2,064 -10,441 -
  QoQ % 1,202.82% 102.64% -44.99% -183.66% 68.27% 80.23% -
  Horiz. % -8.86% -0.68% 25.80% 17.80% 6.27% 19.77% 100.00%
Tax Rate 41.64 % 90.29 % - % - % - % - % - % -
  QoQ % -53.88% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 46.12% 100.00% - - - - -
Total Cost 47,550 47,410 49,319 47,262 46,238 46,531 55,323 -9.61%
  QoQ % 0.30% -3.87% 4.35% 2.21% -0.63% -15.89% -
  Horiz. % 85.95% 85.70% 89.15% 85.43% 83.58% 84.11% 100.00%
Net Worth 57,495 55,149 50,455 43,415 42,241 44,588 51,629 7.45%
  QoQ % 4.26% 9.30% 16.22% 2.78% -5.26% -13.64% -
  Horiz. % 111.36% 106.82% 97.73% 84.09% 81.82% 86.36% 100.00%
Dividend
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Div 0 0 0 0 0 0 0 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Net Worth 57,495 55,149 50,455 43,415 42,241 44,588 51,629 7.45%
  QoQ % 4.26% 9.30% 16.22% 2.78% -5.26% -13.64% -
  Horiz. % 111.36% 106.82% 97.73% 84.09% 81.82% 86.36% 100.00%
NOSH 117,338 117,338 117,338 117,338 117,338 117,338 117,338 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 1.91 % 0.15 % -5.78 % -4.09 % -1.44 % -4.64 % -23.26 % -
  QoQ % 1,173.33% 102.60% -41.32% -184.03% 68.97% 80.05% -
  Horiz. % -8.21% -0.64% 24.85% 17.58% 6.19% 19.95% 100.00%
ROE 1.61 % 0.13 % -5.34 % -4.28 % -1.55 % -4.63 % -20.22 % -
  QoQ % 1,138.46% 102.43% -24.77% -176.13% 66.52% 77.10% -
  Horiz. % -7.96% -0.64% 26.41% 21.17% 7.67% 22.90% 100.00%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 41.31 40.46 39.74 38.69 38.85 37.90 38.25 5.27%
  QoQ % 2.10% 1.81% 2.71% -0.41% 2.51% -0.92% -
  Horiz. % 108.00% 105.78% 103.90% 101.15% 101.57% 99.08% 100.00%
EPS 0.79 0.06 -2.30 -1.58 -0.56 -1.76 -8.90 -
  QoQ % 1,216.67% 102.61% -45.57% -182.14% 68.18% 80.22% -
  Horiz. % -8.88% -0.67% 25.84% 17.75% 6.29% 19.78% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.4900 0.4700 0.4300 0.3700 0.3600 0.3800 0.4400 7.45%
  QoQ % 4.26% 9.30% 16.22% 2.78% -5.26% -13.64% -
  Horiz. % 111.36% 106.82% 97.73% 84.09% 81.82% 86.36% 100.00%
Adjusted Per Share Value based on latest NOSH - 254,635
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
RPS 19.04 18.65 18.31 17.83 17.90 17.46 17.63 5.27%
  QoQ % 2.09% 1.86% 2.69% -0.39% 2.52% -0.96% -
  Horiz. % 108.00% 105.79% 103.86% 101.13% 101.53% 99.04% 100.00%
EPS 0.36 0.03 -1.06 -0.73 -0.26 -0.81 -4.10 -
  QoQ % 1,100.00% 102.83% -45.21% -180.77% 67.90% 80.24% -
  Horiz. % -8.78% -0.73% 25.85% 17.80% 6.34% 19.76% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.2258 0.2166 0.1981 0.1705 0.1659 0.1751 0.2028 7.43%
  QoQ % 4.25% 9.34% 16.19% 2.77% -5.25% -13.66% -
  Horiz. % 111.34% 106.80% 97.68% 84.07% 81.80% 86.34% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 30/06/17 31/03/17 30/12/16 30/09/16 30/06/16 31/03/16 31/12/15 -
Price 1.6800 1.2900 1.3400 1.1900 1.2500 0.6900 0.7350 -
P/RPS 4.07 3.19 3.37 3.08 3.22 1.82 1.92 65.09%
  QoQ % 27.59% -5.34% 9.42% -4.35% 76.92% -5.21% -
  Horiz. % 211.98% 166.15% 175.52% 160.42% 167.71% 94.79% 100.00%
P/EPS 213.11 2,131.93 -58.36 -75.15 -223.93 -39.23 -8.26 -
  QoQ % -90.00% 3,753.07% 22.34% 66.44% -470.81% -374.94% -
  Horiz. % -2,580.02% -25,810.29% 706.54% 909.81% 2,711.02% 474.94% 100.00%
EY 0.47 0.05 -1.71 -1.33 -0.45 -2.55 -12.11 -
  QoQ % 840.00% 102.92% -28.57% -195.56% 82.35% 78.94% -
  Horiz. % -3.88% -0.41% 14.12% 10.98% 3.72% 21.06% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 3.43 2.74 3.12 3.22 3.47 1.82 1.67 61.65%
  QoQ % 25.18% -12.18% -3.11% -7.20% 90.66% 8.98% -
  Horiz. % 205.39% 164.07% 186.83% 192.81% 207.78% 108.98% 100.00%
Price Multiplier on Announcement Date
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Date 24/08/17 31/05/17 27/02/17 24/11/16 24/08/16 30/05/16 26/02/16 -
Price 0.7200 1.4500 1.3600 1.3600 1.0400 1.4900 0.7200 -
P/RPS 1.74 3.58 3.42 3.51 2.68 3.93 1.88 -5.03%
  QoQ % -51.40% 4.68% -2.56% 30.97% -31.81% 109.04% -
  Horiz. % 92.55% 190.43% 181.91% 186.70% 142.55% 209.04% 100.00%
P/EPS 91.33 2,396.35 -59.24 -85.89 -186.31 -84.71 -8.09 -
  QoQ % -96.19% 4,145.16% 31.03% 53.90% -119.94% -947.10% -
  Horiz. % -1,128.92% -29,621.14% 732.26% 1,061.68% 2,302.97% 1,047.10% 100.00%
EY 1.09 0.04 -1.69 -1.16 -0.54 -1.18 -12.36 -
  QoQ % 2,625.00% 102.37% -45.69% -114.81% 54.24% 90.45% -
  Horiz. % -8.82% -0.32% 13.67% 9.39% 4.37% 9.55% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 1.47 3.09 3.16 3.68 2.89 3.92 1.64 -7.04%
  QoQ % -52.43% -2.22% -14.13% 27.34% -26.28% 139.02% -
  Horiz. % 89.63% 188.41% 192.68% 224.39% 176.22% 239.02% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

614  229  596  731 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 EFRAME 0.37+0.025 
 AT 0.09+0.01 
 KANGER 0.17-0.005 
 VC 0.055+0.005 
 MAHSING 1.00+0.02 
 VIVOCOM 0.0450.00 
 LUSTER 0.170.00 
 MRDIY 1.74-0.01 
 MLAB 0.020.00 
 SUPERMX 9.78+0.57 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
2. Traders Brief 26 Oct 2020 - Key Support At 200D SMA To Prevent Further Slide HLBank Research Highlights
3. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
4. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
5. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
6. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
7. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS